Non-Bacterial Types of Cystitis
The primary non-bacterial types of cystitis include interstitial cystitis/bladder pain syndrome (IC/BPS), radiation-induced cystitis, chemotherapy-induced cystitis, eosinophilic cystitis, and ketamine-induced cystitis 1, 2, 3.
Main Categories of Non-Bacterial Cystitis
Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)
This is the most clinically significant non-bacterial cystitis type. IC/BPS is defined as an unpleasant sensation (pain, pressure, discomfort) perceived to be related to the urinary bladder, associated with lower urinary tract symptoms lasting more than six weeks, in the absence of infection or other identifiable causes 1.
IC/BPS presents in two distinct forms:
- Classic (ulcerative) IC: Characterized by Hunner's lesions/ulcers visible on cystoscopy 2, 4
- Non-ulcer IC: More common variant without visible ulceration, presenting with glomerulations on hydrodistension 4
These subtypes differ significantly in their endoscopic findings, histological features, and treatment responses 4.
Radiation-Induced Cystitis
Develops following pelvic radiation therapy for malignancies. This form is preventable with optimal prophylactic measures during cancer treatment, which should be a fixed component of tumor-related therapy 3. The pathophysiology involves damage to the bladder's glycosaminoglycan (GAG) layer.
Chemotherapy-Induced Cystitis
Results from cytotoxic chemotherapy agents, particularly cyclophosphamide and ifosfamide. Like radiation cystitis, preventative therapeutic measures can markedly delay or even prevent development of inflammatory processes 3.
Eosinophilic Cystitis
A rare inflammatory condition characterized by eosinophilic infiltration of the bladder wall 2.
Ketamine-Induced Cystitis
An emerging entity associated with chronic ketamine abuse, presenting with severe bladder symptoms and reduced bladder capacity 2.
Common Pathophysiology
All non-bacterial cystitis types share a common pathophysiologic mechanism: disruption of the bladder's protective glycosaminoglycan layer, leading to increased permeability, exposure of nerve endings, and chronic inflammation 3. This explains why treatments targeting GAG layer repair (such as hyaluronic acid instillations) show efficacy across multiple non-bacterial cystitis types 3.
Critical Diagnostic Consideration
A key pitfall is misdiagnosing IC/BPS as recurrent urinary tract infections, endometriosis, chronic pelvic pain, vulvodynia, or overactive bladder 5. These conditions present with overlapping symptoms of pelvic pain, urinary urgency/frequency, nocturia, and dyspareunia. Moreover, IC/BPS may coexist with these conditions, further complicating diagnosis 5.
Early diagnosis is crucial, as delayed recognition—particularly in interstitial cystitis—can lead to irreversible end-stage disease 3, 6. When first-line therapies (anticholinergics, cyclic antidepressants, or estrogens) fail in patients with sterile urine and cystitis symptoms, non-bacterial cystitis must be considered without delay 6.